美第奇新星生物技術股票討論區

$美第奇新星生物技術(MNOV.US)$ Reuters· 3 mins ago
Medicinova Receives Issue Notification for New Patent Covering Extended-Release Formulations of Mn-166 (Ibudilast)

$美第奇新星生物技術(MNOV.US)$ MediciNova Gets Patent in Japan for Multiple Sclerosis-Related Treatment
WSJ· 2 mins ago

$美第奇新星生物技術(MNOV.US)$Moomoo 24/7
MediciNova Secures Notice Of Grant For New Patent Covering MN-166 (Ibudilast) For Treatment Of Macular Injury In China

$美第奇新星生物技術(MNOV.US)$Moomoo 24/7· 2 mins ago MediciNova Receives Notice Of Decision To Grant For New Patent Covering MN-166 (Ibudilast) For Treatment Of Progressive MS In Europe

$美第奇新星生物技術(MNOV.US)$ phase 2 news hmmm

$美第奇新星生物技術(MNOV.US)$ MediciNova Receives a Notice of Allowance for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Canada

Gainers:
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%, $Workiva(WK.US)$ +15.3%, $Arlo Technologies(ARLO.US)$ +12%, $Array Technologies(ARRY.US)$ +10.3%, $Everbridge(EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US)$ +9.4%, $奧洛茲美醫療(HALO.US)$ +8.7%, $Velo3D(VLD.US)$ +7.6%, $CyberArk(CYBR.US)$ + 6.2%, $美國血液技術(HAE.US)$ +5.8%, $Jackson Financial(JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US)$ +4.8%,...

Gainers:
• $DBV Technologies(DBVT.US)$ +23.5% (positive topline results from Phase 3 EPITOPE Trial)
• $Aldeyra Therapeutics(ALDX.US)$ +19.2% (achieves primary endpoint in phase 3 tranquility-2 trial)
• $美第奇新星生物技術(MNOV.US)$ +11.9% (top-line results from phase 2 clinical trial of MN-166)
• $Torrid(CURV.US)$ +11% (In reaction to earnings/guidance)
• $諾瓦瓦克斯醫藥(NVAX.US)$ +10.1% (FDA advisory committee recommends EUA for its COVID-19 v...